,i #aaith ,,congress #b;d ,session ,h4 ,r4 #ifgb ,,in ,,the ,,house ,,of ,,representatives ,july #ad1 #bjbf,mr4 ,doggett 7for himself and ,mr4 ,smucker7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,public ,health ,service ,act to make updates to the ,vaccine ,injury ,compensation ,program1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,vaccine ,injury ,compensation ,modernization ,act of #bjbf4 #b4 ,changes to ,vaccine ,injury ,compensation ,program 7a7 ,special masters 7#a7 ,establish minimum number of special masters ,section #baab7;c77#a7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ab7;c77#a77 is amended by striking not more than #h and inserting not less than #aj4 7#b7 ,terms ,section #baab7;c77#d7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ab7;c77#d77 is amended to read as follows3 7#d7 ,the appointment of any individual as a special master shall be for an initial term of #d years1 subject to termination under paragraphs 7#b7 and 7#c74 ,an individual appointed as special master may be reappointed to serve one or more additional terms of up to #h years each1 pursuant to paragraph 7#a71 and subject to termination under paragraphs 7#b7 and 7#c74 4 7#c7 ,additional reporting requirements ,section #baab7;c77#f77;,e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ab7;c77#f77;,e77 is amended-- 7,a7 by inserting after disposition of petitions1 the following3 the number of petitions filed that are pending disposition1 the number of hearings scheduled with respect to a pending disposition12 and 7,b7 by inserting 1 including recommendations on whether additional special masters are needed to ensure an expeditious and fair resolution of petitions or otherwise improve the ,program after in the ,program4 7b7 ,recommendations from ,,cdc ,section #baad7;e77#b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ad7;e77#b77 is amended-- 7#a7 in the matter preceding subparagraph 7,a7-- 7,a7 by striking routine administration to children and inserting administration to children1 adults1 or pregnant women2 and 7,b7 by striking within #b years of and inserting within #f months of2 and 7#b7 in subparagraph 7,a71 by striking routine administration to children and inserting administration to children1 adults1 or pregnant women4 7c7 ,increase in compensation 7#a7 ,compensation for death ,section #baae7;a77#b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ae7;a77#b77 is amended to read as follows3 7#b7 ,in the event of a vaccine-related death1 an award of #fjj1jjj4 4 7#b7 ,compensation for pain and suffering ,section #baae7;a77#d7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ae7;a77#d77 is amended to read as follows3 7#d7 ,for actual and projected pain and suffering and emotional distress from the vaccine-related injury1 an award not to exceed #fjj1jjj4 4 7d7 ,increase statute of limitations ,section #baaf7;a77#b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#af7;a77#b77 is amended by striking #cf months and inserting #e years4 7e7 ,program integrity 7#a7 ,including medical records in petitions ,section #baaa7;a77#b77;,a7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#aa7;a77#b77;,a77 is amended1 in the matter preceding clause 7i71 by inserting that includes the medical records and other information required under subsection 7c7 7including1 if applicable1 an identification of unavailable records and explanation of unavailability pursuant to subsection 7c77#c77 after unless a petition4 7#b7 ,decision timing for special masters ,section #baab7;d77#c77;,a77ii7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ab7;d77#c77;,a77ii77 is amended by striking the petition was filed and inserting on which the petition and the medical records and other information required to be filed with such petition under section #baaa7;c7 was filed4 #c4 ,treatment of ,,covid-#ai vaccines 7a7 ,vaccine injury table ,not later than #fj days after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services shall promulgate regulations to add1 in accordance with section #baad7;c77#c7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ad7;c77#c771 ,,covid-#ai vaccines to the ,vaccine ,injury ,table4 ,in promulgating such regulations1 the ,secretary shall provide for notice and opportunity for a public hearing and at least #cj days of public comment4 7b7 ,eligibility for compensation ,notwithstanding sections #cai;,f-#c and #cai;,f-#d of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#f;d2 #db ,u4,s4,c4 #bdg;d-#f;e71 any individual who received a ,,covid-#ai vaccine1 or any other vaccine that is added to the ,vaccine ,injury ,table pursuant to section #baad of such ,act 7#db ,u4,s4,c4 #cjj;aa-#ad71 shall be eligible to file a petition for compensation under section #baaa of such ,act 7#db ,u4,s4,c4 #cjj;aa-#aa71 subject to the requirements of section #baaf of such ,act 7#db ,u4,s4,c4 #cjj;aa-#af74 7c7 ,concurrent remedy ,section #baae7;g7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ae7;g77 is amended by striking the period at the end and inserting 1 or 7#c7 under the ,countermeasures ,injury ,compensation ,program under sections #cai;,f-#c and #cai;,f-#d1 which shall be considered a concurrent remedy4 ,sections #cai;,f-#c and #cai;,f-#d shall not otherwise impact the availability of compensation under this ,act1 with respect to a vaccine-related injury or vaccine-related death4 7d7 ,vaccine ,liability ,rules 7#a7 ,in general ,nothing in this section1 or any amendment made by this ,act1 shall be construed to affect or limit the application of section #cai;,f-#c of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#f;d7 7including the liability protections for covered countermeasures provided under such section7 and any declaration made under such section #cai;,f-#c1 or any amendments made to such a declaration4 7#b7 ,,covid-#ai vaccines ,any civil action 7other than a petition for compensation under the ,national ,vaccine ,injury ,compensation ,program pursuant to section #baaa of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#aa77 that is related to the administration to an individual of a ,,covid-#ai vaccine which was1 at the time of administration1 a covered countermeasure1 will be subject to the procedures specified in section #cai;,f-#c of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#f;d71 regardless of whether the individual involved has filed a petition for compensation pursuant to section #baaa of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#aa7 and elects1 pursuant to section #baba of such ,act 7#db ,u4,s4,c4 #cjj;aa-#ba71 to withdraw the petition or to file a civil action instead of accepting the compensation or judgment on the petition4 7#c7 ,time-barred and ,final ,actions ,nothing in this ,act shall be construed to allow any civil action 7other than a petition for compensation under the ,national ,vaccine ,injury ,compensation ,program pursuant to section #baaa of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#aa77 if1 on the date of enactment of this ,act1 such civil action was time-barred under applicable law or that was the subject of a final judgment or order4 7e7 ,,covid-#ai vaccine defined ,in this section1 the term ,,covid-#ai vaccine refers to any vaccine that is intended to prevent1 mitigate1 or limit the harm from ,,covid-#ai1 or the transmission of ,,sars-,co,v-#b or a virus mutating therefrom1 including any vaccine that is licensed under section #cea of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb7 or authorized for emergency use under section #efd of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bbb-#c71 regardless of the platform or technology used to produce such vaccine4 #d4 ,professional judgment budget 7a7 ,in general ,the ,secretary of ,health and ,human ,services-- 7#a7 in consultation with the ,attorney ,general1 shall submit a budget outlining the resource needs for each agency for purposes of carrying out the ,national ,vaccine ,injury ,compensation ,program under subtitle #b of title ,,xxi of such ,act 7#db ,u4,s4,c4 #cjj;aa-#aj et seq47 for fiscal years #bjbg through #bjca2 and 7#b7 shall submit a budget outlining resource needs for purposes of carrying out the ,countermeasures ,injury ,compensation ,program under section #cai;,f-#d of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d-#f;e7 for fiscal years #bjbg through #bjca4 7b7 ,inclusions ,the budgets described in paragraphs 7#a7 and 7#b7 of subsection 7a7 shall include estimates of both-- 7#a7 the resources necessary to process current backlogs under each program referred to in such subsection2 and 7#b7 each program's ability to reduce processing times for claims under the programs referred to in such paragraphs4 #e4 ,addition of miscellaneous vaccines to list of taxable vaccines 7a7 ,dengue vaccine 7#a7 ,in general ,section #dacb7;a77#a7 of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following new subparagraph3 7,q7 ,any vaccine against dengue4 4 7#b7 ,effective date 7,a7 ,sales1 etc ,the amendment made by paragraph 7#a7 shall apply to sales and uses on or after the later of-- 7i7 the first day of the first month which begins more than #d weeks after the date of the enactment of this ,act1 or 7ii7 the date on which the ,secretary of ,health and ,human ,services lists any vaccine against dengue 7other than any vaccine against dengue listed by the ,secretary prior to the date of the enactment of this ,act7 for purposes of compensation for any vaccine-related injury or death through the ,vaccine ,injury ,compensation ,trust ,fund4 7,b7 ,deliveries ,for purposes of subparagraph 7,a7 and section #daca of the ,internal ,revenue ,code of #aihf1 in the case of sales on or before the effective date described in such subparagraph for which delivery is made after such date1 the delivery date shall be considered the sale date4 7b7 ,,sars-,co,v-#b vaccine 7#a7 ,in general ,section #dacb7;a77#a7 of the ,internal ,revenue ,code of #aihf1 as amended by subsection 7a77#a71 is amended by adding at the end the following new subparagraph3 7,r7 ,any vaccine against ,,sars-,co,v-#b4 4 7#b7 ,effective date 7,a7 ,sales1 etc ,the amendment made by paragraph 7#a7 shall apply to sales and uses on or after the later of-- 7i7 the first day of the first month which begins more than #d weeks after the date of the enactment of this ,act1 or 7ii7 the date on which the ,secretary of ,health and ,human ,services lists any vaccine against ,,sars-,co,v-#b 7other than any vaccine against ,,sars-,co,v-#b listed by the ,secretary prior to the date of the enactment of this ,act7 for purposes of compensation for any vaccine-related injury or death through the ,vaccine ,injury ,compensation ,trust ,fund4 7,b7 ,deliveries 7i7 ,in general ,except as provided in clause 7ii71 for purposes of subparagraph 7,a7 and section #daca of the ,internal ,revenue ,code of #aihf1 in the case of sales on or before the effective date described in such subparagraph for which delivery is made after such date1 the delivery date shall be considered the sale date4 7ii7 ,exception ,clause 7i7 shall not apply to any sale to the ,united ,states ,government4 7c7 ,respiratory syncytial virus vaccine 7#a7 ,in general ,section #dacb7;a77#a7 of the ,internal ,revenue ,code of #aihf1 as amended by subsection 7b77#a71 is amended by adding at the end the following new subparagraph3 7,s7 ,any vaccine against respiratory syncytial virus4 4 7#b7 ,effective date 7,a7 ,sales1 etc ,the amendment made by paragraph 7#a7 shall apply to sales and uses on or after the later of-- 7i7 the first day of the first month which begins more than #d weeks after the date of the enactment of this ,act1 or 7ii7 the date on which the ,secretary of ,health and ,human ,services lists any vaccine against respiratory syncytial virus 7other than any vaccine against respiratory syncytial virus listed by the ,secretary prior to the date of the enactment of this ,act7 for purposes of compensation for any vaccine-related injury or death through the ,vaccine ,injury ,compensation ,trust ,fund4 7,b7 ,deliveries ,for purposes of subparagraph 7,a7 and section #daca of the ,internal ,revenue ,code of #aihf1 in the case of sales on or before the effective date described in such subparagraph for which delivery is made after such date1 the delivery date shall be considered the sale date4 7d7 ,herpes zoster 7shingles7 vaccine 7#a7 ,in general ,section #dacb7;a77#a7 of the ,internal ,revenue ,code of #aihf1 as amended by subsection 7c77#a71 is amended by adding at the end the following new subparagraph3 7,t7 ,any vaccine against herpes zoster 7shingles74 4 7#b7 ,effective date 7,a7 ,sales1 etc ,the amendment made by paragraph 7#a7 shall apply to sales and uses on or after the later of-- 7i7 the first day of the first month which begins more than #d weeks after the date of the enactment of this ,act1 or 7ii7 the date on which the ,secretary of ,health and ,human ,services lists any vaccine against herpes zoster 7shingles7 7other than any vaccine against herpes zoster 7shingles7 listed by the ,secretary prior to the date of the enactment of this ,act7 for purposes of compensation for any vaccine-related injury or death through the ,vaccine ,injury ,compensation ,trust ,fund4 7,b7 ,deliveries ,for purposes of subparagraph 7,a7 and section #daca of the ,internal ,revenue ,code of #aihf1 in the case of sales on or before the effective date described in such subparagraph for which delivery is made after such date1 the delivery date shall be considered the sale date4 7e7 ,routinely administered vaccines 7#a7 ,in general ,section #dacb7;a77#a7 of the ,internal ,revenue ,code of #aihf1 as amended by subsection 7d77#a71 is amended by adding at the end the following new subparagraph3 7,u7 ,any vaccine not described in this paragraph-- 7i7 which either-- 7,i7 is licensed under section #cea of the ,public ,health ,service ,act1 or 7,,ii7 is authorized for emergency use under section #efd of the ,federal ,food1 ,drug1 and ,cosmetic ,act1 and 7ii7 which is commercially distributed in the ,united ,states4 4 7#b7 ,effective date 7,a7 ,sales1 etc ,the amendment made by paragraph 7#a7 shall apply to sales and uses of vaccines described in subparagraph 7,u7 of section #dacb7;a77#a7 of the ,internal ,revenue ,code of #aihf1 as amended by paragraph 7#a71 on or after the later of-- 7i7 the first day of the first month which begins more than #d weeks after the date of the enactment of this ,act1 or 7ii7 the date on which the ,secretary of ,health and ,human ,services lists any such vaccine 7other than any such vaccine listed by the ,secretary prior to the date of the enactment of this ,act7 for purposes of compensation for any vaccine-related injury or death through the ,vaccine ,injury ,compensation ,trust ,fund4 7,b7 ,deliveries ,for purposes of subparagraph 7,a7 and section #daca of the ,internal ,revenue ,code of #aihf1 in the case of sales on or before the effective date described in such subparagraph for which delivery is made after such date1 the delivery date shall be considered the sale date4 7f7 ,clarification of definition of vaccine 7#a7 ,in general ,section #dacb7;a77#b7 of the ,internal ,revenue ,code of #aihf is amended by inserting by stimulating active immunity or by providing passive immunity for long-term protection through long-acting monoclonal antibody products included in recommendations of the ,advisory ,committee on ,immunization ,practices that have been adopted by the ,director of the ,centers for ,disease ,control and ,prevention before the period4 7#b7 ,effective date ,the amendment made by paragraph 7#a7 shall apply to sales and uses on or after the date of the enactment of this ,act4 7g7 ,notification requirement 7#a7 ,in general ,not later than #cj days after a vaccine-- 7,a7 is either-- 7i7 licensed under section #cea of the ,public ,health ,service ,act1 or 7ii7 authorized for emergency use under section #efd of the ,federal ,food1 ,drug1 and ,cosmetic ,act1 and 7,b7 is first commercially distributed in the ,united ,states1 the ,secretary of ,health and ,human ,services shall provide notice of such license or authorization to the appropriate recipients4 7#b7 ,appropriate recipients ,for purposes of paragraph 7#a71 the term appropriate recipients means-- 7,a7 the ,secretary of the ,treasury1 7,b7 the ,committees on ,ways and ,means and ,energy and ,commerce of the ,house of ,representatives1 and 7,c7 the ,committees on ,finance and ,health1 ,education1 ,labor1 and ,pensions of the ,senate4 #f4 ,increase in vaccine excise tax 7a7 ,in general ,section #daca7;b77#a7 of the ,internal ,revenue ,code of #aihf is amended by striking #ge cents and inserting #b4bj4 7b7 ,effective date ,the amendment made by this section shall apply to sales and uses on or after the first day of the first month which begins more than #f months after the date of the enactment of this ,act4